Advertisement
UK markets close in 3 hours 6 minutes
  • FTSE 100

    8,102.38
    +62.00 (+0.77%)
     
  • FTSE 250

    19,741.18
    +21.81 (+0.11%)
     
  • AIM

    755.59
    +0.90 (+0.12%)
     
  • GBP/EUR

    1.1666
    +0.0021 (+0.18%)
     
  • GBP/USD

    1.2503
    +0.0041 (+0.33%)
     
  • Bitcoin GBP

    51,237.67
    -2,046.75 (-3.84%)
     
  • CMC Crypto 200

    1,356.16
    -26.42 (-1.91%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CRUDE OIL

    83.19
    +0.38 (+0.46%)
     
  • GOLD FUTURES

    2,338.90
    +0.50 (+0.02%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    18,002.37
    -86.33 (-0.48%)
     
  • CAC 40

    8,026.90
    -64.96 (-0.80%)
     

If You Had Bought Vilmorin & Cie (EPA:RIN) Stock Three Years Ago, You'd Be Sitting On A 37% Loss, Today

Vilmorin & Cie SA (EPA:RIN) shareholders should be happy to see the share price up 19% in the last month. But that doesn't help the fact that the three year return is less impressive. After all, the share price is down 37% in the last three years, significantly under-performing the market.

See our latest analysis for Vilmorin & Cie

There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.

ADVERTISEMENT

Vilmorin & Cie saw its EPS decline at a compound rate of 14% per year, over the last three years. The 14% average annual share price decline is remarkably close to the EPS decline. So it seems like sentiment towards the stock hasn't changed all that much over time. Rather, the share price has approximately tracked EPS growth.

The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers).

ENXTPA:RIN Past and Future Earnings May 28th 2020
ENXTPA:RIN Past and Future Earnings May 28th 2020

We're pleased to report that the CEO is remunerated more modestly than most CEOs at similarly capitalized companies. But while CEO remuneration is always worth checking, the really important question is whether the company can grow earnings going forward. Dive deeper into the earnings by checking this interactive graph of Vilmorin & Cie's earnings, revenue and cash flow.

What About Dividends?

When looking at investment returns, it is important to consider the difference between total shareholder return (TSR) and share price return. Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. So for companies that pay a generous dividend, the TSR is often a lot higher than the share price return. In the case of Vilmorin & Cie, it has a TSR of -32% for the last 3 years. That exceeds its share price return that we previously mentioned. This is largely a result of its dividend payments!

A Different Perspective

We regret to report that Vilmorin & Cie shareholders are down 11% for the year (even including dividends) . Unfortunately, that's worse than the broader market decline of 7.6%. Having said that, it's inevitable that some stocks will be oversold in a falling market. The key is to keep your eyes on the fundamental developments. Unfortunately, last year's performance may indicate unresolved challenges, given that it was worse than the annualised loss of 6.1% over the last half decade. We realise that Baron Rothschild has said investors should "buy when there is blood on the streets", but we caution that investors should first be sure they are buying a high quality business. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. For instance, we've identified 3 warning signs for Vilmorin & Cie (1 doesn't sit too well with us) that you should be aware of.

But note: Vilmorin & Cie may not be the best stock to buy. So take a peek at this free list of interesting companies with past earnings growth (and further growth forecast).

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on FR exchanges.

Love or hate this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Thank you for reading.